This inventor holds 1 USPTO granted patent. Top assignees: Icahn School of Medicine at Mount Sinai, Rutgers, The State University of New Jersey. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Russell K Durbin: Innovator in Viral Research
Introduction
Russell K Durbin is a notable inventor based in Sergeantsville, NJ (US). He has made significant contributions to the field of viral research, particularly in the development of vaccines against respiratory diseases.
Latest Patents
Durbin holds a patent for "Recombinant Newcastle disease viruses and uses thereof for the prevention of RSV disease or human metapneumovirus disease." This patent describes recombinant Newcastle disease viruses (NDVs) that include a packaged genome with a transgene encoding a respiratory syncytial virus (RSV) F protein or human metapneumovirus (hMPV) F protein. The invention also includes NDVs with a chimeric F protein, which combines elements from both RSV and NDV. These recombinant NDVs are valuable for immunization against RSV and hMPV, aiding in the prevention of related diseases.
Career Highlights
Throughout his career, Durbin has worked with prestigious institutions such as the Icahn School of Medicine at Mount Sinai and Rutgers, the State University of New Jersey. His work has focused on advancing the understanding and treatment of viral infections.
Collaborations
Durbin has collaborated with notable colleagues, including Joan E Durbin and Adolfo Garcia-Sastre, contributing to the advancement of research in his field.
Conclusion
Russell K Durbin's innovative work in viral research and his patent for recombinant Newcastle disease viruses highlight his commitment to improving public health through scientific advancements. His contributions continue to influence the development of vaccines for respiratory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile